TY - JOUR
T1 - Innovations Developed by Patients and Informal Caregivers for Needs Associated to Rheumatic Diseases
AU - Jacinto, Maria João
AU - Oliveira, Pedro
AU - Canhão, Helena
N1 - Funding: The authors are grateful for the funding provided by the Fundação para a Ciência e Tecnologia (FCT) through the project Revolutionizing Healthcare: Empowering patients by valuing innovation and promoting entrepreneurship (PTDC/EGEOGE/32573/2017).
PY - 2021/3/16
Y1 - 2021/3/16
N2 - Until recently, innovation in healthcare was mainly achieved through the development of new drugs, therapies, and medical devices by big pharma and medtech companies; however, the innovative potential for this field is much broader. The patients and caregivers' role in healthcare is often associated with disease management, demand for their own illness data, and its exchange with other patients. However, the patients and caregivers' capacity to innovate to cope with limitations associated with their health condition is a growing phenomenon and starting to be supported by healthcare stakeholders to achieve a truly patient-centric system. Our previous research has shown that these uncommon innovators can develop a wide range of solutions, from simple adaptations and products to highly technological biomedical devices. In this paper, we present novel solutions developed by rheumatic patients, their caregivers, and collaborators, published on the “Patient Innovation” platform (https://patient-innovation.com/), with a focus on the innovator profile, the need that triggers the innovative process, the type of motivation behind the product, and the products developed. The most significant needs that motivate innovation are the will to increase the level of independence (71%) and to be able to perform daily routine activities (65%). In over 80% of cases, the fact that the market does not fully fulfill the needs felt during daily activities is the main motivation to innovate. It is thus concluded that there is room for innovation in rheumatic diseases with solutions developed by patients and informal caregivers that intend to solve needs that the healthcare market is not covering.
AB - Until recently, innovation in healthcare was mainly achieved through the development of new drugs, therapies, and medical devices by big pharma and medtech companies; however, the innovative potential for this field is much broader. The patients and caregivers' role in healthcare is often associated with disease management, demand for their own illness data, and its exchange with other patients. However, the patients and caregivers' capacity to innovate to cope with limitations associated with their health condition is a growing phenomenon and starting to be supported by healthcare stakeholders to achieve a truly patient-centric system. Our previous research has shown that these uncommon innovators can develop a wide range of solutions, from simple adaptations and products to highly technological biomedical devices. In this paper, we present novel solutions developed by rheumatic patients, their caregivers, and collaborators, published on the “Patient Innovation” platform (https://patient-innovation.com/), with a focus on the innovator profile, the need that triggers the innovative process, the type of motivation behind the product, and the products developed. The most significant needs that motivate innovation are the will to increase the level of independence (71%) and to be able to perform daily routine activities (65%). In over 80% of cases, the fact that the market does not fully fulfill the needs felt during daily activities is the main motivation to innovate. It is thus concluded that there is room for innovation in rheumatic diseases with solutions developed by patients and informal caregivers that intend to solve needs that the healthcare market is not covering.
KW - disability
KW - health
KW - patient innovation
KW - rheumatic diseases
KW - user innovation
UR - http://www.scopus.com/inward/record.url?scp=85103393396&partnerID=8YFLogxK
U2 - 10.3389/fmed.2021.647388
DO - 10.3389/fmed.2021.647388
M3 - Article
C2 - 33796544
AN - SCOPUS:85103393396
SN - 2296-858X
VL - 8
JO - Frontiers in medicine
JF - Frontiers in medicine
M1 - 647388
ER -